Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Institutional Investors Approve of SEC’s Shareholder Proxy Changes

Although Milestone and the rest of the SGC would be proud of your discovery, the price is not the point.

Why did they deserve MORE compensation based on corporate and stock performance????

Share
New Message
Please login to post a reply